Re: Berg et al.: Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol (Ophthalmology 2015; 122: 146-52)

Avery Robert L.

首页> 外文期刊>Ophthalmology >Re: Berg et al.: Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol (Ophthalmology 2015; 122: 146-52)

【24h】

Re: Berg et al.: Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol (Ophthalmology 2015; 122: 146-52)

机译：回复：Berg等：根据LUCAS治疗和扩展方案比较兰尼单抗和贝伐单抗治疗新生血管性年龄相关性黄斑变性（Ophthalmology 2015; 122：146-52）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Ophthalmology》 |2016年第2期|共4页
作者
Avery Robert L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Berg et al.: Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol (Ophthalmology 2015; 122: 146-52) REPLY [J] . Bragadottir Ragnheidur, Berg Karina, Pedersen Terje R. Ophthalmology . 2016,第2期

机译：回复：Berg等：根据LUCAS治疗和扩展方案比较兰尼单抗和贝伐单抗治疗与新生血管性年龄相关的黄斑变性（Ophthalmology 2015; 122：146-52）REPLY
2. Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol [J] . Berg Karina, Pedersen Terje R., Sandvik Leiv, Ophthalmology . 2015,第1期

机译：雷尼单抗和贝伐单抗根据LUCAS治疗和扩展方案用于新生血管性年龄黄斑变性的比较
3. Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol Two-Year Results [J] . Berg Karina, Hadzalic Emina, Gjertsen Inger, Ophthalmology . 2016,第1期

机译：根据Lucentis与Avastin研究比较，Ranibizumab或Bevacizumab治疗与新生血管性年龄相关的黄斑变性的治疗和延长方案两年结果
4. Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration [C] . Leilei Zhang, Jeff Xu, Jiwei Huang, Conference on ophthalmic technologies . 2010

机译：贝伐单抗（Avastin）缀合的微泡用于抗VEGF治疗新生血管性年龄相关性黄斑变性
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab [O] . S R Rufai, H Almuhtaseb, R M Paul, 2017

机译：进行系统评价以评估使用兰尼单抗治疗新生血管性年龄相关性黄斑变性的治疗-扩展给药方案
7. Re: Veloso et al.: Vitreomacular interface after anti-vascular endothelial growth factor injections in neovascular age-related macular degeneration (Ophthalmology 2015;122:1569-72) [O] . Sumeet Khanduja, Satvir Singh, Vartika Kinra 2016

机译：Re：Veloso等，valoso等：抗血管内皮生长因子注射后的玻璃体界面相关性黄斑变性（2015年眼科; 122：1569-72）

Re: Berg et al.: Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol (Ophthalmology 2015; 122: 146-52)

著录项

相似文献

相关主题

期刊订阅